About Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to TAB2 mutation
Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to TAB2 mutation is a rare disease catalogued by Orphanet (ORPHA:664401). It is associated with the TAB2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to TAB2 mutation trials.
Search ClinicalTrials.gov for "Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to TAB2 mutation" or filter by Orphanet code ORPHA:664401 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to TAB2 mutation trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to TAB2 mutation. Updated daily.